Research
Tango draws attention with pancreatic cancer combination therapy
STAT and Endpoints News described Tango’s pancreatic cancer combination as promising, but their available snippets give no patient or response figures.
Reported by 2 outlets · Friday, October 23, 2026
Photo: Public domain
The original reports on this story are listed below.
Cancer
In a phase 3 trial, adding intismeran to pembrolizumab reduced recurrence or death risk by 42% compared with pembrolizumab alone.
Reported by 10 outlets
Infectious disease
Kenya has reported nine cases and Nigeria one, as officials investigate whether the first patients crossed paths at Uganda’s Entebbe airport.
Reported by 7 outlets
Health policy
Means resigned from his White House role, with a source telling NBC News that delays to his ultraprocessed-food policy goal were a final straw.
Reported by 5 outlets